| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0,0 € | -100.0% | 945,0 k € | +25.3% | 754,0 k € | -0.0% | 754,1 k € | -21.7% | 963,1 k € | +43.2% | 672,7 k € | -6.6% | 720,0 k € | — | |||||
| EBITDA | 28,9 k € | -76.2% | 121,4 k € | -6.8% | 130,2 k € | -4.0% | 135,5 k € | -11.2% | 152,6 k € | +62.6% | 93,8 k € | +125.1% | -374,1 k € | -381.0% | 133,1 k € | +85.9% | 71,6 k € | +1.2% | 70,7 k € | +394.6% | -24,0 k € | |
| Operating profit | 28,4 k € | -76.5% | 120,9 k € | -6.8% | 129,7 k € | -4.0% | 135,1 k € | -11.2% | 152,1 k € | +64.5% | 92,5 k € | +124.6% | -375,5 k € | -385.8% | 131,4 k € | +86.2% | 70,6 k € | +1.7% | 69,4 k € | +388.6% | -24,0 k € | |
| Profit/loss | 24,7 k € | -79.0% | 117,6 k € | -6.6% | 125,9 k € | -4.7% | 132,2 k € | -97.3% | 5,0 M € | +305.0% | 1,2 M € | +281.3% | -674,9 k € | -117.6% | 3,8 M € | +1467.2% | -281,2 k € | -107.5% | 3,7 M € | +15610.0% | -24,1 k € | |
| Equity | 65,9 M € | +0.0% | 65,8 M € | +0.2% | 65,7 M € | +0.2% | 65,6 M € | +0.2% | 65,5 M € | +0.2% | 65,3 M € | +125.6% | 28,9 M € | -2.3% | 29,6 M € | +14.9% | 25,8 M € | -1.1% | 26,1 M € | +68569.3% | 37,9 k € | |
| Total assets | 66,4 M € | +0.4% | 66,1 M € | +0.2% | 65,9 M € | +0.1% | 65,9 M € | +0.1% | 65,8 M € | +0.4% | 65,5 M € | -0.1% | 65,6 M € | +51.6% | 43,3 M € | +10.2% | 39,2 M € | -3.0% | 40,5 M € | +46362.9% | 87,1 k € | |
| Cash | 174,4 k € | +4.9% | 166,3 k € | -6.6% | 178,0 k € | -2.1% | 181,8 k € | +82.2% | 99,8 k € | -0.2% | 100,0 k € | -2.4% | 102,4 k € | +48.6% | 69,0 k € | +110.8% | 32,7 k € | +431.4% | 6,2 k € | -90.1% | 62,0 k € | |
| Debts | 521,9 k € | +98.5% | 262,9 k € | +11.7% | 235,3 k € | -12.5% | 268,9 k € | -25.8% | 362,2 k € | +46.9% | 246,5 k € | -99.3% | 36,7 M € | +170.6% | 13,5 M € | +1.5% | 13,3 M € | -6.4% | 14,3 M € | +29122.2% | 48,8 k € | |
Public limited company · Antwerpen · incorporated on 27/11/2015
Public limited company profitable and well capitalised.
Solid counterparty for a standard engagement.
HistoGeneX Holding is a Public limited company incorporated in 2015. Its main activity is: Activities of holding companies. Its registered office is in Antwerpen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette